Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 24, 2018
The non-exclusive license grants Voyager rights to use the AlivaMab Mouse for antibody drug discovery and development.
read more
Advarra has completed all integration activities.
read more
Idifarma has begun its seventh project with Spanish biotechnology company, Palobiofarma.
read more
Rigel has entered into an exclusive license and supply agreement with Kissei to develop and commercialize Tavalisse in all current and potential indications in Japan, China, Taiwan and Korea.
read more
Piramal Pharma Solutions (PPS) announced the launch of its Xcelerate Integrated Solutions platform.
read more
CANbridge and WuXi Biologics jointly announced a strategic partnership to enable CANbridge to develop and commercialize a portfolio of biotherapeutics for the treatment of rare diseases.
read more
Alcami announced its collaboration with MDGH, a not-for-profit Australian biopharmaceutical company dedicated to the development of affordable medicines and vaccines for neglected diseases prevalent in low and middle-income countries.
read more
PCI Pharma Services is celebrating the installation of its 80th Serialization line, further extending its position across its global supply network.
read more
Thermo Fisher Scientific opened its new business center and biorepository in Frederick, Md. with a ribbon-cutting ceremony.
read more
Wednesday, October 31, 2018
Dr. Reddy’s Laboratories announced the launch of Atomoxetine Capsules, USP, a therapeutic equivalent generic version of Stratter (atomoxetine) Capsules in the United States.
read more
Wednesday, October 31, 2018
Capua BioServices has announced the completion of the renovation of one of the recovery and purification plants, at its facility in Capua, Italy.
read more
Wednesday, October 31, 2018
WuXi Biologics announced that construction has commenced on a Biologics Manufacturing Center of excellence (MFG8), in the city of Shijiazhuang, one hour train from Beijing.
read more
Wednesday, October 31, 2018
Acerus announced the signing of an amendment to its existing licensing and supply agreement with medac, expanding the exclusive right to 28 current EU member countries.
read more
Wednesday, October 31, 2018
Celerion announced the implementation of FibroScan to complement a suite of soluble biomarkers Celerion has validated to support nonalcoholic steatohepatitis (NASH) clinical studies.
read more
Wednesday, October 31, 2018
Rho announced its membership in The Avoca Quality Consortium (AQC), a collaborative focused on quality and compliance in the execution of clinical trials.
read more